Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 13 NIH 12 NETWORK 5 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pneumonia 1 Lung Diseases, Interstitial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 152 Carboplatin 116 Cisplatin 70 Paclitaxel 68 Pemetrexed 65 Gemcitabine 63 Bevacizumab 59 Docetaxel 48 Fluorouracil 46 Oxaliplatin 45 Dexamethasone 44 durvalumab 35 Leucovorin 35 Capecitabine 33 Rituximab 32 atezolizumab 30 Lenalidomide 30 Fulvestrant 30 Injections 29 Cyclophosphamide 29 Prednisone 28 Nivolumab 27 Letrozole 26 Cetuximab 26 130-nm albumin-bound paclitaxel 26 venetoclax 24 pomalidomide 24 enzalutamide 22 Irinotecan 21 daratumumab 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observation × 30 days × Clear all

NCT06192004 2026-05-04

LOOP

AstraZeneca

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡